Skip to content

Drug interactions

Glimepiride-pioglitazone + Rucaparib

Severity: Moderate

Glimepiride-pioglitazone and Rucaparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib inhibits CYP2C9, which metabolizes glimepiride. Glimepiride levels may rise, which increases the risk of hypoglycemia.

What this interaction means in plain words

Glimepiride-pioglitazone and Rucaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Glimepiride-pioglitazone belongs to Endocrine; Rucaparib belongs to Oncology.

Evidence level: Moderate

Why it happens

Rucaparib inhibits CYP2C9, which reduces glimepiride clearance.

What to do

Monitor blood glucose closely when rucaparib is started or stopped and reduce the glimepiride dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glimepiride-pioglitazone with Rucaparib?

MediHelp rates the interaction as moderate. Glimepiride-pioglitazone and Rucaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rucaparib inhibits CYP2C9, which metabolizes glimepiride. Glimepiride levels may rise, which increases the risk of hypoglycemia.

How serious is the interaction between Glimepiride-pioglitazone and Rucaparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when rucaparib is started or stopped and reduce the glimepiride dose if hypoglycemia occurs.

What other medicines interact with Glimepiride-pioglitazone?

MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in